TELA Bio (TELA) Other Accumulated Expenses (2018 - 2026)

TELA Bio's Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $546000.0 for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 50.9% year-over-year to $546000.0 in Q1 2026; TTM through Mar 2026 was $546000.0, a 50.9% decrease from a year earlier, with the FY2025 full-year figure at $711000.0, up 48.43% from the prior year.
• Other Accumulated Expenses fell to $546000.0 in Q1 2026 per TELA's latest filing, from $711000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $1.2 million in Q2 2025 and bottomed at $51000.0 in Q1 2022.
• The 5-year median for Other Accumulated Expenses is $527000.0 (2023), against an average of $533588.2.
• Across the five-year window, Other Accumulated Expenses sank 91.72% in 2022 and jumped 285.9% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $146000.0 in 2022, then surged by 260.96% to $527000.0 in 2023, then slipped by 9.11% to $479000.0 in 2024, then soared by 48.43% to $711000.0 in 2025, then decreased by 23.21% to $546000.0 in 2026.
• Per Business Quant, the three latest TELA Other Accumulated Expenses figures stand at $546000.0 (Q1 2026), $711000.0 (Q4 2025), and $1.2 million (Q3 2025).